Pharmacokinetics (PK) of etanercept are unaltered by concurrent administration of methotrexate (MTX) in rheumatoid arthritis (RA) patients.

被引：0
|
作者：
Zhou, HH [1 ]
Buckwalter, M [1 ]
Mayer, P [1 ]
Raible, D [1 ]
Wajdula, J [1 ]
Fatenejad, S [1 ]
Sanda, M [1 ]
机构：
[1] Wyeth Res, Collegeville, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
253
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of etanercept are unaltered by concurrent administration of methotrexate in rheumatoid arthritis patients
    Zhou, H
    Zitnik, R
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A53 - A53
  • [2] Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis
    Zhou, HH
    Mayer, PR
    Wajdula, J
    Fatenejad, S
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (11): : 1235 - 1243
  • [3] Concomitant tacrolimus (TAC) and methotrexate (MTX) pharmacokinetics (PK) in rheumatoid arthritis (RA) patients.
    Holum, MB
    Wisemandle, W
    Bekersky, I
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1053 - 1053
  • [4] Effects of renal insufficiency on pharmacokinetics of methotrexate (MTX) in rheumatoid arthritis (RA) patients.
    Combe, B
    Kinowski, JM
    Bologna, C
    Sany, J
    Bressolle, F
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 382 - 382
  • [5] EFFECTS OF ETODOLAC ON METHOTREXATE (MTX) PHARMACOKINETICS IN RHEUMATOID-ARTHRITIS (RA) PATIENTS
    ANAYA, JM
    FABRE, D
    BRESSOLLE, F
    ALRIC, R
    DROPSY, R
    SANY, J
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S343 - S343
  • [6] Folic acid alters methotrexate (MTX) disposition in rheumatoid arthritis (RA) patients.
    Combe, B
    Kinowski, JM
    Pouly, B
    Sany, J
    Bressolle, F
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S76 - S76
  • [7] Pharmacokinetics (PK) of etanercept in ankylosing spondylitis (AS) patients were similar to those in rheumatoid arthritis (RA) patients
    Zhou, H
    Buckwalter, M
    Boni, J
    Wajdula, J
    Fatenejad, S
    Raible, D
    Mayer, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 416 - 416
  • [8] ENBREL® (etanercept) in addition to methotrexate (MTX) in rheumatoid arthritis (RA):: Long-term observations
    Burge, DJ
    Weinblatt, ME
    Kremer, JM
    Fleischmann, RM
    Bankhurst, AD
    Bulpitt, KJ
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 : 106 - 106
  • [9] Treatment of interleukin-1 receptor antagonist in combination with methotrexate (MTX) in rheumatoid arthritis (RA) patients.
    Cohen, S
    Hurd, E
    Cush, JJ
    Schiff, MH
    Weinblatt, ME
    Moreland, IW
    Bear, M
    Rich, W
    McCabe, DP
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S273 - S273
  • [10] METHOTREXATE (MTX) METABOLISM IN RHEUMATOID-ARTHRITIS (RA)
    GALIVAN, J
    KAMEN, B
    KREMER, JM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 194 - 194
12345